Eagle Pharmaceuticals
EGRX
#11130
Rank
ยฃ2.5 M
Marketcap
ยฃ0.19
Share price
0.00%
Change (1 day)
-79.99%
Change (1 year)

Eagle Pharmaceuticals (EGRX) - Total debt

Total debt on the balance sheet as of June 2023 : ยฃ54.49 Million

According to Eagle Pharmaceuticals 's latest financial reports the company's total debt is ยฃ54.49 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Eagle Pharmaceuticals - Total debt on balance sheet (from 2013 to 2023)

Total debt by year

Year Total debt Change
2022-12-31ยฃ52.9 M165.3%
2021-12-31ยฃ19.94 M-20.66%
2020-12-31ยฃ25.13 M-20.69%
2019-12-31ยฃ31.69 M-9.41%
2018-12-31ยฃ34.98 M-1.05%
2017-12-31ยฃ35.35 M
2013-09-30N/A-100%
2012-09-30ยฃ5.31 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
ยฃ33.97 B 62,248.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ36.75 B 67,357.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
ยฃ37.66 B 69,023.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ43.60 B 79,916.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ34.09 B 62,470.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ23.92 B 43,798.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
ยฃ12.83 B 23,462.10%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel